No, abdominal ultrasound is not appropriate for evaluating constipation in this clinical scenario.
Plain abdominal X-ray has already confirmed the presence of constipation (stool burden), and ultrasound would not add meaningful diagnostic or therapeutic value at this stage. The focus should shift from further imaging to optimizing medical management of her constipation.
Why Ultrasound is Not Indicated
The abdominal X-ray has already accomplished the primary diagnostic goal—confirming the presence of constipation 1. While emerging research suggests ultrasound can assess rectal diameter and colonic contents 2, this is primarily a research tool without established clinical thresholds for management decisions. Ultrasound cannot provide information that would change your treatment approach beyond what the X-ray has already shown.
The key clinical question is not "Is there constipation?" (already answered), but rather "Why is treatment failing and what needs to change?"
Critical Evaluation Needed
Given that constipation started after a back injury in a 32-year-old woman, you must consider:
- Neurogenic bowel dysfunction from the back injury (spinal cord or cauda equina involvement)
- Medication-related constipation if she's taking opioids for back pain 3, 4
- Mechanical obstruction that requires urgent intervention
- Inadequate laxative dosing despite current regimen
Rule out red flags immediately: Perform a thorough neurological examination looking for saddle anesthesia, urinary retention, lower extremity weakness, or loss of anal sphincter tone that would suggest cauda equina syndrome requiring emergency MRI of the spine—not abdominal imaging.
Appropriate Next Steps
1. Optimize Current Laxative Regimen
Your patient is on polyethylene glycol (Emolax) and senna (Senokot), which is appropriate first-line therapy 5, 6. However, the doses may be inadequate:
- Increase polyethylene glycol: Titrate up to 1-2 capfuls (17-34g) daily or even twice daily 6
- Increase senna: Can escalate to 2-3 tablets 2-3 times daily with goal of one non-forced bowel movement every 1-2 days 7
2. Add Second-Line Agents
If optimization fails within 48-72 hours:
- Bisacodyl 10-15 mg daily to three times daily 7
- Magnesium-based products (magnesium hydroxide 30-60 mL daily-BID or magnesium citrate 8 oz daily) 7
3. Consider Manual Intervention
If impaction is present (assess with digital rectal exam):
- Glycerin suppositories 7
- Bisacodyl suppository (10 mg rectally daily-BID) 7
- Manual disimpaction with pre-medication (analgesic ± anxiolytic) 7
- Enemas (tap water or mineral oil retention) 7
4. Address Underlying Cause
If she's taking opioids for back pain, this is likely opioid-induced constipation requiring:
- Prophylactic bowel regimen with stimulant laxative (senna) with or without stool softener 3, 4
- Consider peripherally acting μ-opioid receptor antagonists (methylnaltrexone, naloxegol, naldemedine) if standard laxatives fail 7, 4
When Further Imaging IS Appropriate
Additional imaging would be indicated if:
- CT abdomen/pelvis with IV contrast: If you suspect bowel obstruction, perforation, or other acute abdominal pathology (peritoneal signs, severe pain, vomiting) 8
- MRI spine: If neurological examination suggests cauda equina syndrome
- Defecography or anorectal manometry: Only if constipation persists despite optimal medical management and you suspect pelvic floor dysfunction 1
Common Pitfall
The most common error is ordering additional imaging when the diagnosis is already established and treatment hasn't been adequately optimized. Constipation visible on X-ray requires therapeutic escalation, not more imaging. The temporal relationship to her back injury is the critical clue that demands neurological assessment and consideration of opioid use—neither of which ultrasound can evaluate.
Reassess in 3-6 weeks after treatment optimization 1. If symptoms persist despite maximal medical therapy, then consider specialized testing for colonic transit time or anorectal function 1—but ultrasound still would not be the appropriate choice.